PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma.

Journal:

Journal of Clinical Oncology

Published:

2025-05-17

DOI:

10.1200/jco-24-02210

Affiliations:

20

Authors:

20

Go to article

Institutions	Authors	Share
Hôpital Trousseau, France	1.000000	0.05
Dynamique des cellules tumorales, France	1.000000	0.05
Hopital Prive Saint-Claude, France	1.000000	0.05
Rouen University Hospital-Charles Nicolle (CHU de Rouen), France	1.000000	0.05
CHU de Reims, France	1.000000	0.05
Institute Gustave-Roussy (IGR), France	1.000000	0.05
Hôpital Privé des Côtes d'Armor, France	1.000000	0.05
AP-HP Pitié-Salpêtrière Hospital, France	1.000000	0.05
Hôpital Européen Marseille, France	1.000000	0.05
Institute of Cancer Research (ICO), France	1.000000	0.05
UNICANCER Group, France	1.000000	0.05
Hôpital Rangueil, CHU-Toulouse, France	1.000000	0.05
Centre François Baclesse, France	1.000000	0.05
Centre Oscar Lambret, France	1.000000	0.05
CHU Caen, France	1.000000	0.05
Centre Antoine-Lacassagne (CAL), France	1.000000	0.05
Hospital Center De Saint Malo, France	1.000000	0.05
Hôpital Édouard Herriot, HCL, France	1.000000	0.05
CHU Limoges, France	1.000000	0.05
Hôpitaux Civils de Colmar (HCC), France	1.000000	0.05

Interested in Oncology and Carcinogenesis?